0000899243-15-003023.txt : 20150813
0000899243-15-003023.hdr.sgml : 20150813
20150813122111
ACCESSION NUMBER: 0000899243-15-003023
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150811
FILED AS OF DATE: 20150813
DATE AS OF CHANGE: 20150813
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Global Blood Therapeutics, Inc.
CENTRAL INDEX KEY: 0001629137
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 274825712
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 EAST JAMIE COURT, SUITE 101
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650741-7700
MAIL ADDRESS:
STREET 1: 400 EAST JAMIE COURT, SUITE 101
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brown Willie L. Jr.
CENTRAL INDEX KEY: 0001650411
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37539
FILM NUMBER: 151049654
MAIL ADDRESS:
STREET 1: C/O GLOBAL BLOOD THERAPEUTICS, INC.
STREET 2: 400 EAST JAMIE COURT, SUITE 101
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-08-11
0
0001629137
Global Blood Therapeutics, Inc.
GBT
0001650411
Brown Willie L. Jr.
C/O GLOBAL BLOOD THERAPEUTICS, INC.
400 EAST JAMIE COURT, SUITE 101
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
Stock Option (right to buy)
20.00
2015-08-11
4
A
0
15000
A
2025-08-10
Common Stock
15000
15000
D
Stock Option (right to buy)
20.00
2015-08-11
4
A
0
8600
A
2025-08-10
Common Stock
8600
8600
D
The shares subject to this option shall vest and become exercisable in 12 equal monthly installments with the first installment on September 11, 2015, such that this option is fully exercisable on August 11, 2016. This option is subject to accelerated vesting upon a change of control of the Issuer.
Not applicable.
The shares subject to this option shall vest and become exercisable in 36 equal monthly installments with the first installment on August 23, 2015, such that this option is fully exercisable on July 23, 2018. This option is subject to accelerated vesting upon a change of control of the Issuer.
/s/ John Schembri, as Attorney-in-Fact
2015-08-13